(Reuters) - Canada's Valeant Pharmaceuticals International Inc
Valeant, which expects to get regulatory nod by early August, said severance plans for the United States and Canada have been finalized.
The company also said it is plans to consolidate some locations.
(Reporting by Krithika Krishnamurthy in Bangalore; Editing by Sriraj Kalluvila)
(c) Copyright Thomson Reuters 2013. Check for restrictions at: http://about.reuters.com/fulllegal.asp